by Sodium phenylbutyrate is a medication used to treat acute hyperammonemia due to propionic acidemia or methylmalonic acidemia in patients one month of age and older and chronic management of patients with urea cycle disorders. It works by altering the metabolism of nitrogen-containing compounds in order to diminish the production of toxic nitrogenous end products associated with urea cycle disorders. The medication is available in a variety of forms including tablets, capsules and powder for oral administration depending on the age and needs of the individual patient. Sodium phenylbutyrate decreases the risk of complications from elevated ammonia levels and preserves neurological function which is of utmost importance for patients with urea cycle disorders.
The global Sodium Phenylbutyrate Market is estimated to be valued at US$ 1.92 Billion in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the sodium phenylbutyrate market is the development of new drug delivery methods to improve patient compliance. Currently, sodium phenylbutyrate has to be taken multiple times a day via oral administration which can be difficult for pediatric patients and caregivers. Researchers are working on reformulating sodium phenylbutyrate into extended release formulations that only need to be taken once daily. This will help reduce the pill burden and simplify dosing schedules which is expected to significantly improve treatment adherence especially in younger patients. Such new product formulations in the pipeline are anticipated to drive the growth of the sodium phenylbutyrate market during the forecast period.
Porter’s Analysis
Threat of new entrants: The threat is moderate as substantial capital is required to setup manufacturing facilities and R&D to develop new formulations.
Bargaining power of buyers: Buyers have moderate bargaining power as there are multiple established players. However, switching costs are low.
Bargaining power of suppliers: Suppliers have moderate bargaining power as raw materials require specialized production processes with limited alternatives available.
Threat of new substitutes: The threat is low as sodium phenylbutyrate has specified applications and not many substitutes present for its usage in conditions like urea cycle disorders.
Competitive rivalry: The competition is high among major players to grow their market share and use differentiation strategies for new product launches.
Key Takeaways
The Global Sodium Phenylbutyrate Market Demand is expected to witness high growth.
Regional analysis: North America is expected to dominate the global sodium phenylbutyrate market during the forecast period. This is attributed to higher treatment rate for conditions requiring sodium phenylbutyrate therapy and growing awareness about urea cycle disorders.
Key players operating in the sodium phenylbutyrate market are Procter & Gamble (P&G) Chemicals, CREMER, Wilmar, VVF Ltd., KLK OLEO, Inoue Perfumery MFG, Wuhan Yuancheng Gongchuang, Changsha Jianglong Chemicals, and Godrej Industries.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
